Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ALX Oncology Holdings Q2 Adj. EPS $(0.44) Beats $(0.45) Estimate

Author: Benzinga Newsdesk | August 12, 2025 03:15pm
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.45) by 2.22 percent. This is a 29.03 percent increase over losses of $(0.62) per share from the same period last year.

Posted In: ALXO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist